BMY.RT
Ensign Peak Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,986,676
| Closed | -$1.37M | – | 1936 |
|
|
2020
Q4 | $1.37M | Buy |
1,986,676
+1,295,999
| +188% | +$894K | ﹤0.01% | 1260 |
|
|
2020
Q3 | $1.55M | Buy |
690,677
+401,099
| +139% | +$902K | ﹤0.01% | 1105 |
|
|
2020
Q2 | $1.04M | Buy |
289,578
+26,590
| +10% | +$95.2K | ﹤0.01% | 1270 |
|
|
2020
Q1 | $1M | Buy |
262,988
+221,694
| +537% | +$843K | ﹤0.01% | 1169 |
|
|
2019
Q4 | $124K | Buy |
+41,294
| New | +$124K | ﹤0.01% | 1639 |
|